Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > Congratulations??

<< Previous

Bullboard Posts

Next >>

Comment by Trogarzonon May 13, 2024 8:41pm

70 Views

Post# 36037867

RE:Congratulations??

For what... 96% drop in the market cap... for nominating Paul... for beoing irresponsible with our retirement money by betting the farm on Th1902... for what. It's insulting to legacy shareholder and comple te lack of jugement one again.. In the same ballpark as the celebrating of getting 12.5M from IQ for 20% of the company. Total lack of decency and jugement. You are an insult to me and other long term patient and loyal shareholders. You made our retirement mony vanish.. that's what you did and you congratulate yourselves for it. Hope the same happens to you one day.

<< Previous

Bullboard Posts

Next >>

Unlocking potential in TAG Oil’s Badr Oilfield Abu-Roash 'F' project